The Bionic Eye
Is the human being just a glorified silicon chip? At
least the scientists who are hell-bent on integrating electronic circuits
with human tissue seem to think so. Analogous to the cochlear implant, a
bionic eye has now been developed. Eighteen visually impaired people (many
with retinitis pigmentosa) in the US, Europe and Mexico have been
implanted with the bionic eye or retinal prosthesis (Argus II; Second
Sight Medical Products, Inc; California).
The patient wears eyeglasses which have a camera on one
of the lenses. Images are sent to a video processor. Information is
transformed into electronic signals and transmitted wirelessly to a
receiver on the surface of the eye. This goes via a tiny cable to an
electrode array implanted in the retina. When the retina is stimulated,
the signals are perceived in the brain. With time the brain adapts to
understand the meaning of these signals. Initial results are promising,
with 11 patients reporting they can see a door 6 meters away and walk on a
20 foot line drawn on the floor (Scientific American, 4th
March 2009).
Audacity of Hope
A fertility clinic in the US recently made the
audacious offering to create babies in whom cosmetic traits like hair and
eye color can be chosen. They planned to do it using preimplantation
genetic diagnosis (PGD). The claim caused a furore in the global media.
Criticisms from many quarters included scientists who feel the technology
is not yet there for cosmetic manipulation. Even the Pope decried what he
termed as "an obsessive search for the perfect child". In view of the
public outcry, the clinic has now halted its plans.
Ethical conundrums such as these are bound to come up
again and again. How far can we allow genetic tinkering? In a society
which has accepted cosmetic surgery, will PGD for physical traits be far
behind? Will there be choice in adding genes for longevity and
intelligence? Some even contemplate that it may create a new divide: the
‘genrich’ and the ‘genpoor’ ie those with or without a designer
genome (Scientific American 4, March 2009).
The Recession and Healthcare
In some ways the recent global recession has given a
push to medical tourism in India. Worker healthcare costs are a major
burden for US industries. Wellpoint, the largest health benefits company
in the US, announced a new international medical tourism product aimed at
helping recession-struck American corporates cut their healthcare costs.
Members can opt for elective procedures to be done in two of the Apollo
group hospitals in Bangalore or New Delhi. Those insured with BlueCross
BlueShield (one of the largest health insurer in the US), who are tied up
with Companion Global Healthcare, can now exercise an option of getting
treated at Wockhardt Hospitals in India. So for Indian hospitals it may
just well be boom time (Times of India, 3 March 2009, Business World, 8
December 2008).